WST

West Pharmaceutical Services, Inc.

Healthcare · $26.2B market cap

Verdict

Share price

$364.98

close of Oct 3, 2026

Fair value

$135.86

Sticker Price

Payback Price

$54.34

buy price

Overpriced

WST is Overpriced: at $364.98 it trades 169% above its fair value of $135.86. Its buy price (Payback Price) is $54.34, 85% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.

How we valued it

Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.

Business quality

4 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth14.1% a year✓
Equity per share growth10.5% a year✓
Sales growth6.7% a year✗
Free cash flow growth17.0% a year✓
Return on invested capital15.7%✓

Follow WST

Get notified when it reaches its buy price of $54.34. Free.

Create a free account

Superinvestors

2 of the investors we track hold WST. In Q2 2026, 1 trimmed and 1 sold out. Who we track

Moves in Q2 2026

Trimmed: Hillman Capital Management

Sold out: Viking Global Investors

Insider activity

Since Jun 30, 2026: no open-market purchases, 1 sale worth $852K and 14 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works